SG
SLXN

StoneX Group’s Silexion Therapeutics Corp Ordinary Shares SLXN Stock Holding History

StoneX Group’s Portfolio SLXN Stock Details SLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$9.11K Buy
+749
New +$9.11K ﹤0.01% 839